Try our beta test site
1 study found for:    S0905
Show Display Options
Rank Status Study
1 Active, not recruiting Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Epithelioid Mesothelioma;   Pleural Malignant Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatoid Mesothelioma
Interventions: Drug: Cediranib Maleate;   Drug: Cisplatin;   Other: Laboratory Biomarker Analysis;   Drug: Pemetrexed Disodium;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.